Rabi Hanna - Cell & Gene therapy Doc
@rabihannamd.bsky.social did:plc:bv356wcjbcdymwzuipl5nz6h
Chief of Pediatric hem-Onc & BMT @ClevelandClinic #CleClinicCancer @cleclinickids #CleClinicPedsCancer #ChildhoodCancer #pedcsm #bmtsm. Posts are my own opinion.
Bei Bluesky seit
- Follower
- 245
- Folgt
- 51
- Posts
- 53
- Tage in Ranglisten
- 0
Zusammenfassung
Rabi Hanna - Cell & Gene therapy Doc (@rabihannamd.bsky.social) ist seit 27 November 2024 auf Bluesky. Das Konto hat 245 Follower, folgt 51 Konten und hat 53 Posts veröffentlicht.
Ranglisten-Platzierungen
Die besten Tage, an denen Posts dieses Kontos in Debyas Tagesliste kamen.
Dieses Konto war noch in keiner Tagesrangliste.
Zuletzt gelikte Posts
Öffentliche Likes aus dem Bluesky-Netzwerk.
www.nejm.org/doi/full/10.... www.nejm.org/doi/full/10.... www.nejm.org/doi/full/10.... @harvardmed.bsky.social @clevelandclinic.bsky.social @drheeney.bsky.social @hfrangoul.bsky.social @rabihannamd.bsky.social
Post anzeigen#ASH25 #bmtsm Kim: of those with cGVHD 54% steroid refractory, 96% of whom recd Rux and few went on to need later lines of therapy. 2yr OS 85% with Haplo, 82% MUD, 77% MMUD. NRM 7-10% for Haplo/MUD, 16% with MMUD.
Post anzeigen#ASH25 #bmtsm Soiffer: although cGVHD reduced overall, this benefit of cryo was not seen in pts getting PTCy. Given higher OS in spite of lower GRFS with cryo, fresh grafts remain the preferred standard (but still reasonable when logistically useful).
Post anzeigenHear about Dr. Storb’s impact on #Hematology: m.youtube.com/watch?v=302N... #ASH25 #HemeSky
Post anzeigen#ASH25 #leusm Miltiadous: Higher pre-HCT gut flora diversity associated with improved post-HCT survival in adults. Here, 327 peds ongoing first allo were evaluated, but all slides requested no reposting so I can’t share with you. 🤷🏻♂️
Post anzeigen
Blockierte Konten
Blockierungen sind auf Bluesky öffentlich.
Dieses Konto blockiert niemanden.